Benzinga | Aug 5, 2021 07:38AM EDT

Autolus Therapeutics Q2 EPS $(0.47) Beats $(0.50) Estimate, Sales $138.00K Miss $190.00K Estimate

Autolus Therapeutics (NASDAQ:AUTL) reported quarterly losses of $(0.47) per share which beat the analyst consensus estimate of $(0.50) by 6 percent. This is a 24.19 percent increase over losses of $(0.62) per share from the same period last year. The company reported quarterly sales of $138.00 thousand which missed the analyst consensus estimate of $190.00 thousand by 27.37 percent. This is a 52.90 percent decrease over sales of $293.00 thousand the same period last year.